{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:33:19Z","timestamp":1788910399249,"version":"build-2803163510"},"reference-count":95,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Allergic conditions, such as asthma, chronic urticaria, atopic dermatitis (AD), and eosinophilic esophagitis, have long been treated with oral and topical steroids which resulted in negative off\u2010target effects. However, newer biologic medications are increasingly being developed and approved for treatment of these conditions. These medications have a variety of mechanisms of action to target pathophysiology specific to these diseases. As biologics become more targeted, fewer off\u2010target effects are seen improving tolerability for patients as well as expanded options for treatment of these conditions. This review discusses monoclonal antibody therapies (omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab, tezepelumab, and tralokinumab) including their safety and use in asthma, chronic urticaria, AD, and eosinophilic esophagitis.<\/jats:p>","DOI":"10.1111\/cts.13546","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T05:43:59Z","timestamp":1683870239000},"page":"1294-1308","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The evolving landscape of immunotherapy for the treatment of allergic conditions"],"prefix":"10.1111","volume":"16","author":[{"given":"Aarti","family":"Pandya","sequence":"first","affiliation":[{"name":"Children's Mercy Kansas City  Kansas City Missouri USA"},{"name":"University of Missouri\u2010Kansas City School of Medicine  Kansas City Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esosa","family":"Adah","sequence":"additional","affiliation":[{"name":"Children's Mercy Kansas City  Kansas City Missouri USA"},{"name":"University of Missouri\u2010Kansas City School of Medicine  Kansas City Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgette","family":"Jones","sequence":"additional","affiliation":[{"name":"Children's Mercy Kansas City  Kansas City Missouri USA"},{"name":"University of Missouri\u2010Kansas City School of Medicine  Kansas City Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7628-6007","authenticated-orcid":false,"given":"Rachel","family":"Chevalier","sequence":"additional","affiliation":[{"name":"Children's Mercy Kansas City  Kansas City Missouri USA"},{"name":"University of Missouri\u2010Kansas City School of Medicine  Kansas City Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0737-4"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.4137\/CCRPM.S7793"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.038"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.01.033"},{"key":"e_1_2_8_6_1","first-page":"106","article-title":"Nucala (mepolizumab): first IL\u20105 antagonist monoclonal antibody FDA approved for maintenance treatment of patients with severe asthma","volume":"9","author":"Fala L","year":"2016","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.09.033"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S111862"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000549"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0396OC"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S78049"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.642359"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015868"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804092"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31191-1"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3336"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304048"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610020"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034975"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19573"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61536-6"},{"key":"e_1_2_8_25_1","volume-title":"Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Section 2, Definition, Pathophysiology and Pathogenesis of Asthma, and Natural History of Asthma","author":"National Asthma Education and Prevention Program TEPotDaMoA","year":"2007"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00598-2019"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.12701\/yujm.2020.00647"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.03.010"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01310.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201208-1414OC"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-9-201105030-00002"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/11597160-000000000-00000"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0120OC"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00772.x"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010834.pub2"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14235"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30031-5"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2020.100462"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00042-9"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S227170"},{"key":"e_1_2_8_41_1","unstructured":"LugogoN KlineJN HirschI GoldmanM ZangrilliJG TrudoF.Benralizumab improves morning peak expiratory flow while reducing Oral corticosteroid dosages for patients with severe uncontrolled asthma in the ZONDA phase III trial. American Thoracic Society 2018 International Conference; San Diego Convention Center.2018."},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201810-1944CI"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0702-4"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2106567"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704064"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30179-5"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.306"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.01.031"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2018.10.4.370"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.02.049"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13345"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.04.012"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2011.09.008"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215372"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.08.023"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3447"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13675"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.11.018"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.08.014"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900408"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042803"},{"key":"e_1_2_8_63_1","volume-title":"Middleton's Allergy E\u2010Book: Principles and Practice","author":"Burks AW","year":"2019"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.002"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2007.00572.x"},{"issue":"1","key":"e_1_2_8_66_1","first-page":"44","article-title":"Impact of atopic dermatitis on health\u2010related quality of life in Spanish children and adults: the PSEDA study","volume":"104","author":"S\u00e1nchez\u2010P\u00e9rez J","year":"2013","journal-title":"Actas Dermosifiliogr"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.033969"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70051-5"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.12.1563"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10030.x"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38376.439653.D3"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.05.046"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.023"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.054"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16928"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19574"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00588-2"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30732-7"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.01.017"},{"issue":"21","key":"e_1_2_8_80_1","first-page":"2093","article-title":"Anti\u2010Interleukin\u201031 receptor a antibody for atopic dermatitis","volume":"376","author":"Ruzicka T","year":"2017","journal-title":"N Engl J Med"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1290205"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2014.02.002"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1502863"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.08.017"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.06.065"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.5.2464"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.09.042"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.12.347"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.09.007"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.178558"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.044"},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.09.007"},{"key":"e_1_2_8_93_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.05.036"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113483"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2266"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12096"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.13546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T19:55:34Z","timestamp":1694894134000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.13546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":95,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1111\/cts.13546"],"URL":"https:\/\/doi.org\/10.1111\/cts.13546","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"assertion":[{"value":"2022-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}